Pfizer Doxorubicin Hydrochloride

Doxorubicin Hydrochloride is a potent, trusted solution in the fight against cancer, part of Pfizer’s innovative chemotherapy lineup. This cytotoxic anthracycline antibiotic is available in concentrations of 10 mg/5 ml, 20 mg/10 ml, 50 mg/25 ml, and 200 mg/100 ml, tailored to meet varying clinical needs. It is meticulously packaged in single-dose vials and Cytosafe multiple-dose vials to ensure safe handling and administration.

This drug is a cornerstone in cancer treatment protocols, offering significant efficacy against a range of cancers, including breast, bladder, and lymphomas, among others. It operates by disrupting the growth of cancer cells, leading to cell death while mitigating the spread of malignancies. Trusted by healthcare professionals, it combines reliability and scientific innovation to provide robust support in tailored cancer treatment plans.

• Packaged in sterile single-dose and Cytosafe multiple-dose vials for safe and effective administration.
• Available in various concentrations to cater to different dosage requirements in chemotherapy regimens.
• Easy-to-use injectable form, designed to allow precise dosing and maximum patient safety.

• Doxorubicin Hydrochloride is primarily used in the treatment of various types of cancers, including breast cancer, bladder cancer, Kaposi’s sarcoma, lymphoma, and acute lymphocytic leukemia. It works by slowing or stopping the growth of cancer cells.
• Doxorubicin can also be used in combination with other chemotherapy drugs to enhance treatment efficacy. Its systemic approach allows it to target cancer cells throughout the body, providing comprehensive treatment for pervasive malignancies.

1. How is Doxorubicin administered?
Doxorubicin is administered via intravenous injection by a healthcare professional in a clinical setting.

2. Is Doxorubicin safe?
While Doxorubicin is effective, it can have side effects, and its administration should be monitored by medical professionals.